Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

PHLEBOFA™ tablets 600mg, 30pcs

🔥 6 items sold in last 3 hours
16 people are viewing this product
  • Phlebofa™ Tablets 600Mg, 30Pcs Buy Online 4
  • Phlebofa™ Tablets 600Mg, 30Pcs Buy Online 6
  • Phlebofa™ Tablets 600Mg, 30Pcs Buy Online 8
Brand:
Active Ingredient:

Manufacturer:

$98.0

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

PHLEBOFA™ tablets 600mg, 30pcs

$83.5
Add to cart

Analogs of PHLEBOFA™

ANGIORUS™ tablets 50mg+450mg, 60pcs

$98.0
Add to cart

ANGIORUS™ tablets 100mg+900mg, 30pcs

$121.5
Add to cart

ANGIORUS™ tablets 100mg+900mg, 60pcs

$180.0
Add to cart

ANGIORUS™ tablets 50mg+450mg, 30pcs

$70.0
Add to cart

Table of Contents

PHLEBOFA™ 600mg Tablets Buy Online

PHLEBOFA Tablets: A Comprehensive Overview

Experiencing the discomfort of leg heaviness, swelling, or pain? PHLEBOFA tablets may offer a potential solution. This comprehensive overview explores the uses, benefits, and considerations surrounding this medication.

PHLEBOFA 600mg tablets are designed to address the symptoms associated with venous and lymphatic insufficiency. Its primary function is to improve circulation and reduce swelling in the legs. The active ingredient, diosmin, is a bioflavonoid known for its positive effects on vascular health.

This medication’s effectiveness stems from its ability to strengthen blood vessel walls, improve blood flow, and reduce inflammation. These actions contribute to alleviating the discomfort often associated with venous disorders, providing relief from symptoms like pain, swelling, and heaviness in the legs.

Understanding PHLEBOFA

PHLEBOFA tablets, containing 600mg of diosmin, are a medication designed to alleviate symptoms associated with venous and lymphatic insufficiency. Diosmin is a bioflavonoid with recognized angioprotective and venotonic properties. It works by improving blood circulation and reducing inflammation within the veins and lymphatic system, ultimately providing relief from the discomfort caused by these conditions. The specific mechanisms of action involve reducing vascular permeability, enhancing venous tone, and improving lymphatic drainage.

Understanding the role of diosmin is key to comprehending PHLEBOFA’s effectiveness. This active ingredient doesn’t simply mask symptoms; it directly addresses the underlying issues contributing to venous insufficiency. By strengthening capillary walls and improving microcirculation, it tackles the root causes of leg pain, swelling, and heaviness. This targeted approach distinguishes PHLEBOFA from simple pain relievers, offering a more comprehensive solution for managing venous disorders. The formulation ensures that the diosmin is readily absorbed and effectively distributed throughout the body to maximize its therapeutic impact.

Furthermore, the formulation of PHLEBOFA tablets is designed for optimal bioavailability. The bioavailability of a medication refers to the proportion of the drug that enters the bloodstream and becomes available to exert its effects. A high bioavailability ensures that the therapeutic dose of diosmin reaches the target tissues efficiently. This contributes to the overall effectiveness of PHLEBOFA in alleviating symptoms and improving the overall health of the venous system. This efficient delivery system is a critical factor in the medication’s efficacy.

Key Indications for Use

PHLEBOFA tablets are primarily indicated for the symptomatic treatment of chronic venous insufficiency (CVI). This encompasses a range of conditions characterized by impaired venous return, leading to various unpleasant symptoms. The medication’s effectiveness lies in its ability to target and alleviate these symptoms, improving the overall quality of life for those affected. It’s crucial to remember that PHLEBOFA is not a cure for CVI but rather a tool to manage its symptoms.

Specifically, PHLEBOFA is often prescribed to address the following:

  • Leg heaviness and pain: A common symptom of CVI, often described as an aching or throbbing sensation, particularly at the end of the day.
  • Swelling (edema): Fluid retention in the legs and ankles, often worsened by prolonged standing or sitting.
  • Leg cramps: Nocturnal leg cramps or muscle spasms are frequently experienced by individuals with venous insufficiency.
  • Restless legs syndrome (RLS): Although not directly a symptom of CVI, RLS often coexists and can be exacerbated by the underlying venous issues, making PHLEBOFA a potential supportive therapy.
  • Varicose veins: While PHLEBOFA doesn’t eliminate varicose veins, it can alleviate the associated discomfort and reduce the risk of complications.

It’s important to note that while PHLEBOFA can effectively manage these symptoms, it should be used as part of a broader approach to managing CVI, which may include lifestyle modifications and other therapeutic interventions. Consulting with a healthcare professional is crucial to determine the suitability of PHLEBOFA and develop a comprehensive treatment plan tailored to individual needs. Always follow the prescribed dosage and duration of treatment for optimal results.

Dosage and Administration

The recommended dosage and administration of PHLEBOFA tablets should always be followed as directed by a healthcare professional. Self-adjusting the dosage can be detrimental to health and should be strictly avoided. The prescribed regimen is tailored to the individual’s specific condition and response to treatment; therefore, it’s crucial to adhere to the instructions provided.

Generally, the standard dosage for chronic venous insufficiency involves taking one 600mg tablet daily. This single daily dose is typically sufficient to achieve the desired therapeutic effect. However, the timing of administration can vary depending on individual circumstances and physician recommendations. Some healthcare providers may recommend taking the tablet in the morning, while others might suggest a different time of day.

For acute conditions such as hemorrhoids, a different dosage schedule might be prescribed. In such cases, the initial dosage might be higher (e.g., one tablet three times a day for the first four days) and then gradually reduced (e.g., one tablet twice a day) as the condition improves. This adjusted regimen aims to provide rapid relief during the acute phase and then transition to a maintenance dose. Always consult your doctor for specific instructions regarding dosage and duration of treatment for any condition.

It’s important to emphasize that the duration of treatment is also determined by individual needs and the severity of the condition. Treatment courses generally extend for several weeks or months, and consistent adherence to the prescribed regimen is essential to maximize therapeutic benefits. Regular follow-up appointments with your healthcare provider allow for monitoring of progress and necessary adjustments to the treatment plan.

Pros of Using PHLEBOFA

PHLEBOFA offers several advantages in managing the symptoms of venous and lymphatic insufficiency. Its effectiveness in alleviating discomfort is a significant benefit for many patients. The convenient once-daily dosage contributes to ease of use and improved patient compliance, leading to better treatment outcomes. This simplicity makes it a more manageable option compared to medications requiring multiple daily doses.

The medication’s mechanism of action directly targets the underlying causes of venous insufficiency, rather than just masking symptoms. This targeted approach leads to more sustainable relief and improved long-term management of the condition. By strengthening blood vessel walls and improving circulation, PHLEBOFA addresses the root problems contributing to discomfort, resulting in a more comprehensive approach to treatment.

Furthermore, PHLEBOFA’s generally good safety profile and low incidence of side effects make it a well-tolerated option for many patients. This favorable safety profile allows for long-term use, which is often necessary for managing chronic conditions like venous insufficiency. The availability of PHLEBOFA in a convenient tablet form further enhances its practicality and ease of use for patients.

In summary, the key advantages of PHLEBOFA include:

  • Effective symptom relief: Reduces leg pain, swelling, and heaviness.
  • Convenient dosage: Once-daily administration improves compliance.
  • Targeted mechanism of action: Addresses underlying causes of venous insufficiency.
  • Generally good safety profile: Well-tolerated with minimal side effects.

Cons of Using PHLEBOFA

While PHLEBOFA is generally well-tolerated, potential drawbacks should be considered. Although infrequent, some individuals may experience mild gastrointestinal side effects such as nausea, diarrhea, or abdominal discomfort. These side effects are usually mild and transient, resolving spontaneously without requiring treatment discontinuation. However, if these symptoms persist or worsen, consulting a healthcare professional is advisable.

Another potential consideration is the possibility of drug interactions. Although not extensively documented, the possibility of interactions with other medications cannot be entirely ruled out. Therefore, it’s crucial to inform your healthcare provider of all medications, including over-the-counter drugs and supplements, you are currently taking to minimize the risk of any adverse interactions. This proactive approach ensures the safest and most effective use of PHLEBOFA.

Furthermore, individual responses to medication can vary. While PHLEBOFA is effective for many, it might not provide complete relief for all patients. The effectiveness of the treatment can depend on factors such as the severity of the underlying condition and individual patient characteristics. It’s important to have realistic expectations and to discuss any concerns about treatment efficacy with your doctor.

In summary, the potential drawbacks of PHLEBOFA include:

  • Gastrointestinal side effects: Nausea, diarrhea, or abdominal discomfort are possible, though infrequent.
  • Potential drug interactions: Inform your doctor about all medications you are taking.
  • Variability in response: Effectiveness may vary depending on individual factors.

Mechanism of Action

PHLEBOFA’s therapeutic effects stem from its primary active ingredient, diosmin, a bioflavonoid with proven efficacy in improving venous and lymphatic function. Diosmin’s mechanism of action is multifaceted, targeting several key aspects of venous insufficiency. It works by reducing inflammation, strengthening blood vessel walls, and improving blood flow, all of which contribute to alleviating the symptoms associated with venous disorders.

One of diosmin’s primary actions is to reduce vascular permeability. This means it strengthens the walls of blood vessels, preventing fluid leakage into surrounding tissues. This reduction in permeability is crucial in alleviating swelling (edema), a common symptom of venous insufficiency. By strengthening the vessel walls, diosmin helps maintain the integrity of the circulatory system and prevents fluid buildup in the legs and ankles.

Furthermore, diosmin exhibits a venotonic effect, meaning it increases the tone and strength of the veins. This improved venous tone enhances venous return, facilitating the efficient transport of blood back to the heart. The improved venous return reduces venous congestion and pressure, leading to a reduction in pain, swelling, and other related symptoms. This enhanced venous return is a crucial aspect of diosmin’s therapeutic benefit.

Finally, diosmin also improves lymphatic drainage. The lymphatic system plays a critical role in fluid balance and waste removal. By stimulating lymphatic drainage, diosmin assists in clearing excess fluid from the tissues, further contributing to the reduction of swelling and inflammation. This combined effect on venous and lymphatic systems makes diosmin a powerful tool for managing venous insufficiency.

Precautions and Contraindications

Before starting PHLEBOFA treatment, it’s crucial to discuss any pre-existing health conditions with your doctor. This is especially important for individuals with known allergies or sensitivities to any of the medication’s components. Open communication ensures the safe and effective use of the medication, minimizing potential risks or adverse reactions. A thorough medical history review helps your doctor assess the suitability of PHLEBOFA for your specific circumstances.

While generally well-tolerated, PHLEBOFA should be used cautiously in individuals with certain conditions. For example, those with a history of severe liver or kidney disease should exercise caution and discuss the risks and benefits with their doctor before commencing treatment. This cautious approach is crucial to prevent any potential complications or exacerbations of pre-existing health issues. Individual risk factors and contraindications should always be carefully considered.

Furthermore, pregnant or breastfeeding women should consult their physician before using PHLEBOFA. The use of medication during pregnancy or breastfeeding requires careful evaluation to ensure both maternal and fetal/infant safety. A healthcare professional can assess the potential benefits and risks and guide the appropriate course of action. This cautious approach prioritizes the well-being of both mother and child.

Finally, it’s essential to note that PHLEBOFA is intended for symptomatic relief and should not be considered a primary treatment for severe venous disorders. Severe cases of venous insufficiency may require more extensive medical intervention. Always seek professional medical advice for diagnosis and management of significant venous issues. This ensures that appropriate and comprehensive treatment is received.

Conclusion

PHLEBOFA 600mg tablets offer a valuable option for the symptomatic management of chronic venous insufficiency and related conditions. Its primary active ingredient, diosmin, effectively targets the underlying mechanisms contributing to venous discomfort, providing relief from symptoms such as leg pain, swelling, and heaviness. The once-daily dosage regimen enhances patient compliance, contributing to better treatment adherence and overall effectiveness.

While PHLEBOFA presents numerous benefits, it’s crucial to remember that individual responses to medication can vary. Potential side effects, though generally mild and infrequent, should be considered. Furthermore, a comprehensive approach to managing venous insufficiency often involves lifestyle modifications and other therapeutic interventions in addition to medication. Therefore, consulting a healthcare professional is essential for accurate diagnosis, personalized treatment planning, and ongoing monitoring.

Before starting any medication, including PHLEBOFA, it is crucial to consult with a doctor to discuss your medical history, potential drug interactions, and any concerns you may have. This proactive approach ensures that the treatment is both safe and effective for your individual needs. Remember that self-treating can be dangerous, and professional medical guidance is vital for optimal health outcomes. A collaborative approach between patient and physician is key to achieving the best possible results.

Ultimately, PHLEBOFA can be a valuable tool in managing the symptoms of venous disorders, providing relief and improving the quality of life for many individuals. However, responsible use, informed by medical advice, is paramount to ensuring its safe and effective application. Always prioritize open communication with your doctor to ensure the best possible treatment plan for your specific condition.

  • Phlebofa™ Tablets 600Mg, 30Pcs Buy Online 10
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Phlebofa™ Tablets 600Mg, 30Pcs Buy Online 12
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Phlebofa™ Tablets 600Mg, 30Pcs Buy Online 14
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “PHLEBOFA™ tablets 600mg, 30pcs”

Your email address will not be published. Required fields are marked

Similar products

LIOTON™ 1000 topical gel 1000IU/g (30g), 1pc

$52.0
Add to cart

XARELTO™ tablets 20mg, 98pcs

$949.5
Add to cart

COPLAVIX™ tablets 100mg+75mg, 100pcs

$418.5
Add to cart

COPLAVIX™ tablets 100mg+75mg, 28pcs

$120.5
Add to cart

DIORIDINVEL™ tablets 50mg+450mg, 60pcs

$85.0
Add to cart

DETRAVENOL™ tablets 500mg, 30pcs

$63.5
Add to cart

DETRAGEL™ topical gel 100IU/g+10mg/g+10mg/g (40g), tube 1pc

$58.5
Add to cart

DETRAGEL™ topical gel 100IU/g+10mg/g+10mg/g (80g), tube 1pc

$94.0
Add to cart

DETRALEX™ tablets 1000mg, 18pcs

$94.0
Add to cart

DETRALEX™ tablets 1000mg, 30pcs

$152.0
Add to cart

DETRALEX™ tablets 500mg, 30pcs

$87.5
Add to cart

DETRALEX™ tablets 500mg, 30pcs

$87.5
Add to cart

HEPARIN-AKRI™ 1000 topical gel 1000IU/g (50g), 1pc

$49.0
Add to cart

HEPARIN topical gel 1000IU/g (30g), 1pc

$41.0
Add to cart

VENOLIFE™ topical gel 0.25%+5%+2% (35g), tube 1pc

$45.0
Add to cart

VENARUS™ tablets 100mg+900mg, 30pcs

$140.0
Add to cart

VENARUS™ tablets 50mg+450mg, 60pcs

$125.5
Add to cart

ASCORUTIN™ tablets 50mg+50mg, 50pcs

$13.5
Add to cart

ARIXTRA™ solution for IV and SC injection 5mg/ml (0.3ml), 10 syringes

$337.0
Add to cart

ANGIORUS™ tablets 50mg+450mg, 30pcs

$70.0
Add to cart

ANGIORUS™ tablets 50mg+450mg, 60pcs

$98.0
Add to cart

ANGIORUS™ tablets 100mg+900mg, 60pcs

$180.0
Add to cart

ALPROSTADIL lyophilisate for infusion solution 20mcg, ampoules 10pcs

$643.0
Add to cart

ACTOVEGIN™ injection solution 40mg/ml (10ml), 5pcs

$125.5
Add to cart
Select your currency